Author response for "Interim Analysis of a Phase 2 <scp>Open‐Label</scp> Trial Assessing Burosumab Efficacy and Safety in Patients With <scp>Tumor‐Induced</scp> Osteomalacia"
crossref（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要